The global bone graft substitute market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The bone graft substitute is a synthetic inorganic or biologically organic combination which can be inserted for the treatment of a bone defect. The rise in the prevalence of orthopedic injuries such as wrist fractures, ankle fractures, stress fractures, and more are anticipated to drive the demand of the global bone graft substitute market. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2019, approximately 178 million new fracture cases and 455 million cases of acute long-term symptoms of a fracture were registered in 2019. The standard rate of fractures accounted for 2296 incident cases per 100,000 population. Out of these, ankle fractures were the most common and burdensome fracture in 2019 with an age-standardized incidence rate of 419 cases per 100,000 population.
The rising adoption of synthetic bone grafts owing to their offered benefits such as availability, sterility, and morbidity is further anticipated to drive the growth of the market. I March 2022, Molecular Matrix Inc. has announced the launch of Osteo-P BGS. The Osteo –P BGS is a non-mineralized, synthetic bone void filler created from edge hyper-crosslinked carbohydrate polymer technology. It allows surgeons to easily manipulate and maximize direct contact with viable host bone. This product provides an opportunity for real-time healing visualization, as remodeling can be observed radiographically.
Looking towards the demand for bone graft substitutes, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Baxter International Inc. had launched Altapore Shape bioactive bone graft. It is designed to enhance bone growth and assist achieve fusion, which can lead to reduced pain. Further, in January 2019, Bioventus had launched Osteomatrix+, for use in bone remodeling in a variety of orthopedic and spine applications.Osteomatrix+ is a bone graft substitute consisting of bovine collagen and biphasic designed to produce sustained osteoconductivity throughout the bone remodeling process. Thus, such product launches are anticipated to accelerate the growth of the global bone graft substitutes market during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Bone Graft Substitute Marketat https://orionmarketreports.com/request-sample/?id=93766&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Bayer AG, Pfizer Inc, Novo Nordisk, and Octapharma among others.
A full report is available at: https://orionmarketreports.com/global-bone-graft-substitute-market/93766/
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Product
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Baxter International Inc, Molecular Matrix Inc, and Bioventus among others.
Global Bone Graft Substitute Market Report by Segment
By Type
- Autograft
- Allograft
- Determineralized Bone Matrix (DBM)
- Synthetic
- Xenograft
By Application
- Spinal Fusion
- Joint reconstruction
- Ankle and Foot
- Others
By End-User
- Hospital
- Specialty Clinics
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
